A, O, G, Eduarda.; ARAÚJO, Eduarda Oliveira Gomes de.
Abstract:
Since the past centuries, medicinal plants were the main source for the treatment and prevention
of health problems that society had. According to data from the World Health Organization
(WHO), there are estimates that about 80% of the population make use of medicinal plants. The
new coronavirus, SARS CoV-2, of the Coronaviridae family, is a virus that causes respiratory
infections causing moderate and severe cases, and, in 2020, the COVID-19 pandemic. In view
of the above, the review aimed to identify the species of medicinal plants and their by-products,
used by the population in the period of the Covid-19 pandemic in the Amazon. Capes Periodical
data, LILACS, PUBMED, and Google academic, using the keywords: Covid-19; Amazon;
Medicinal plants, natural extracts and their combinations. 45 families and 89 species were
mentioned, with leaves and bark being the most used. As a method of preparation, infusion and
decoction were the most used. At work, Garlic (Allium sativum), Ginger (Zingiber officinale
L.), Sangre De Grado (Croton lecheri), Cat's Claw (Uncaria tomentos), Copaiba (Copaifera
multijuga L.), Blackberry (Rubus fruticosus), Mastruz ( Chenopodium ambrosioides L.),
Cinnamon (Cinnamomum verum), Mint (Mentha arvensis L.), Cotton (Gossypium hirsutum),
Cantaloupe (Momordica charantia L.), Jambu (Acmella oleracea), Andiroba (Carapa guianensis
Aubl.) , Lemon (Citrus limon), Eucalyptus (Eucalyptus globulus), Soursop (Annona muricata
L.), and Passion fruit (Passiflora edulis), suffered the highest citation among the articles, with
the species Cinnamon (Cinnamomum verum), Copaíba (Copaifera langsdorffii), Eucalyptus
(Eucalyptus globulus), Garlic (Allium sativum L.), Cat's claw (Uncaria tomentosa), Ginger
(Zingiber officinale), and Jambu (Acmella oleracea) have demonstrated antiviral and anti-
SARS-CoV action -two. They have desirable biological activity for the symptoms caused by
Covid-19, so further studies and tests on these structures may represent the development of
pharmacological potential.